First-line (1L) ribociclib (RIB) plus endocrine therapy (ET) vs combination chemotherapy (combo CT) in clinically aggressive hormone receptor (HR)+/HER2-advanced breast cancer (ABC): A subgroup analysis of patients (pts) with or without liver metastases (mets) from RIGHT Choice.

El Saghir N. S., Im S., Azim H. A., Eralp Y., Yap Y. S., Sandhu M. S., ...Daha Fazla

JOURNAL OF CLINICAL ONCOLOGY, cilt.43, sa.16_SUPPL, 2025 (SCI-Expanded, Scopus)

• Yayın Türü: Makale / Özet
• Cilt numarası: 43 Sayı: 16_SUPPL
• Basım Tarihi: 2025
• Doi Numarası: 10.1200/jco.2025.43.16_suppl.1069
• Dergi Adı: JOURNAL OF CLINICAL ONCOLOGY
• Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, CINAHL, EMBASE, MEDLINE, Nature Index
• Acıbadem Mehmet Ali Aydınlar Üniversitesi Adresli: Hayır